The future opportunities and remaining challenges in the application of nanoparticle‐mediated hyperthermia combined with chemo‐radiotherapy in cancer
WIREs Nanomedicine and Nanobiotechnology · 2023
DOI: 10.1002/wnan.1922 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift WIREs Nanomedicine and Nanobiotechnology, 2023. Verfasst von Sakine Shirvalilou und 7 weiteren Autor:innen. Beteiligte Einrichtung: Finetech in Medicine Research Center, Iran University of Medical Sciences, Tehran, Iran. Hauptthemen laut MEDLINE: Hyperthermia, Induced, Neoplasms, Nanoparticles. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 174 Literaturangaben.
Abstract (Originalsprache)
A pivotal cause of death in the modern world, cancer is an insidious pathology that should be diagnosed at an early stage for successful treatment. Development of therapeutic interventions with minimal invasiveness and high efficacy that can discriminate between tumor and normal cells is of particular interest to the clinical science, as they can enhance patient survival. Nanoparticles are an invaluable asset that can be adopted for development of such diagnostic and therapeutic modalities, since they come in very small sizes with modifiable surface, are highly safe and stable, and can be synthesized in a controlled fashion. To date, different nanoparticles have been incorporated into numerous modalities such as tumor‐targeted therapy, thermal therapy, chemotherapy, and radiotherapy. This review article seeks to deliver a brief account of recent advances in research and application of nanoparticles in hyperthermia‐based cancer therapies. The most recent investigations are summarized to highlight the latest advances in the development of combined thermo‐chemo‐radiotherapy, along with the challenges associated with the application of nanoparticles in cancer therapy. This article is categorized under: Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Finetech in Medicine Research Center, Iran University of Medical Sciences, Tehran, Iran.
- Department of Medical Physics, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.
- Cellular and Molecular Research Center, Research Institute of Cellular and Molecular Sciences in Infectious Diseases, Zahedan University of Medical Sciences, Zahedan, Iran.
- Pharmacology Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
- Infectious and Tropical Diseases Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
ORCID-Profile: Zahed Tavangari, Mohammad Hossein Parsaei, Saman Sargazi, Habib Ghaznavi, Samideh Khoei
Zitieren
APA
Shirvalilou, S., Tavangari, Z., Parsaei, M. H., Sargazi, S., Sheervalilou, R., Shirvaliloo, M., Ghaznavi, H., & Khoei, S. (2023). The future opportunities and remaining challenges in the application of nanoparticle‐mediated hyperthermia combined with chemo‐radiotherapy in cancer. WIREs Nanomedicine and Nanobiotechnology. https://doi.org/10.1002/wnan.1922
Vancouver
Shirvalilou S, Tavangari Z, Parsaei MH, Sargazi S, Sheervalilou R, Shirvaliloo M, et al. The future opportunities and remaining challenges in the application of nanoparticle‐mediated hyperthermia combined with chemo‐radiotherapy in cancer. WIREs Nanomedicine and Nanobiotechnology. 2023. doi:10.1002/wnan.1922
BibTeX
@article{Shirvalilou2023,
author = {Shirvalilou, Sakine and Tavangari, Zahed and Parsaei, Mohammad Hossein and Sargazi, Saman and Sheervalilou, Roghayeh and Shirvaliloo, Milad and Ghaznavi, Habib and Khoei, Samideh},
title = {The future opportunities and remaining challenges in the application of nanoparticle‐mediated hyperthermia combined with chemo‐radiotherapy in cancer},
journal = {WIREs Nanomedicine and Nanobiotechnology},
year = {2023},
doi = {10.1002/wnan.1922}
}
EUVIMED